CLINICAL TRIALS PROFILE FOR ETHINYL ESTRADIOL; NORGESTIMATE
✉ Email this page to a colleague
All Clinical Trials for ETHINYL ESTRADIOL; NORGESTIMATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00236769 ↗ | A Study of Efficacy and Safety With the Transdermal Contraceptive System. | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 | 1997-11-01 | The purpose of the study is to evaluate the contraceptive efficacy, safety, cycle control, and compliance with the transdermal contraceptive system. |
NCT00254865 ↗ | A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 1 | 2002-08-01 | The objective of this study is to compare the levels of the hormones norelgestromin, norgestrel, and ethinyl estradiol in the bloodstream of healthy female volunteers administered ORTHO EVRA® (a transdermal contraceptive patch) and CILEST® (an oral contraceptive). The open-label treatment phase of the study consists of two 28-day cycles of one treatment, a washout period of 28 days, and crossover to two 28-day cycles of the other treatment. |
NCT00301587 ↗ | A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives | Withdrawn | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 | 1969-12-31 | The purpose of this study is to compare red blood cell folate levels in women who are taking oral contraceptives with or without folic acid |
NCT00320567 ↗ | The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia Nervosa | Completed | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | Phase 2 | 1969-12-31 | The purpose of this study is to evaluate the effect of norgestimate/ethinyl estradiol on lumbar spine (L1-L4) and total hip bone mineral density (BMD) in pediatric subjects with anorexia nervosa. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ETHINYL ESTRADIOL; NORGESTIMATE
Condition Name
Clinical Trial Locations for ETHINYL ESTRADIOL; NORGESTIMATE
Trials by Country
Clinical Trial Progress for ETHINYL ESTRADIOL; NORGESTIMATE
Clinical Trial Phase
Clinical Trial Sponsors for ETHINYL ESTRADIOL; NORGESTIMATE
Sponsor Name
Sponsor Name for ETHINYL ESTRADIOL; NORGESTIMATE | |
Sponsor | Trials |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 9 |
Bristol-Myers Squibb | 5 |
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | 2 |
[disabled in preview] | 2 |
This preview shows a limited data set Subscribe for full access, or try a Trial |